CFMATTERS

What's New in Health and Life Sciences

News from the European Comission

EUROPA - Research and Innovation: Health & Life Sciences

EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Health web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
imageFinnish firm Mobidiag has received a EUR 15-million loan extended by the InnovFin Infectious Diseases Finance Facility under the EU's Horizon 2020 programme. Provided by the European Investment Bank, the loan is accelerating the development of fast, life-saving tests for small laboratories.
ImageThe widespread adoption of magnetic resonance imaging (MRI) revolutionised clinical medicine, and the revolution has not stopped. Scientists in an EU-funded project are exploring ways to make MRIs even more effective - aiming to help patients get the best possible treatment through early disease detection.
Pancreatic cancer is a leading cause of cancer-related death. Technology from an EU-funded project could guide surgery to remove pancreatic tumours and target post-operative radiotherapy to cancerous cells, improving patients' chances of survival.
ImageAn EU-funded project is using slime mould to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market. The devices can also be used for citizen science applications.
ImageCoronary heart disease is a leading cause of death worldwide, but identifying those at high risk remains difficult. EU-funded research has helped identify new biomarkers that will improve diagnosis and lead to new and better treatment options.
ImageA wide variety of conditions can affect the brain, complicating patients' interaction with the world around them. Although the psychosocial difficulties faced by people living with such illnesses are often underestimated, an EU-funded project has revealed they are often similar across a wider range of mental disorders. Thus, more general and cross-cutting approaches can help to mitigate a wide range of common disease-associated psychosocial problems. Greater awareness of this should help improve patient care.
ImageA clinical study led by EU-funded researchers is administering a promising Parkinson's drug to the first human patients - delivering it directly to the brain using an innovative drug device.
ImageEU-funded researchers have shown that a daily medical nutrition drink can help to stabilise everyday cognitive and functional performance in elderly people.

The conference is organised by the Centre of Excellence in Computational Biomedicine (CompBioMed), aimed at nurturing and promoting the uptake and exploitation of high performance computing within the biomedical modelling community.

Located at the Institute of Engineering and Technology London: Savoy Place, the CompBioMed Conference 2019 will combine a venue with innovative catering and spectacular views of the River Thames with an exciting programme of relevant symposia and world-renowned plenary and invited speakers, proposed and secured by our International Organising Committee.

In addition to the conference, we have an associated event at the London Science Museum.

Home
Menu
Search
Top

Newsletter Subscription

News Section

More than 200 patients recruited to the CFMATTERS study Read more

Social Media

Facebook CFMATTERS LinkedIn CFMATTERS
Home
Menu
Search
Top